Bernardi S, Stacul F, Zecchin M, Dobrinja C, Zanconati F, Fabris B
Department of Medical, Surgical and Health Sciences, University of Trieste, Medicina Clinica, Cattinara Teaching Hospital, Strada di Fiume, 34149, Trieste, Italy.
SS Endocrinologia (UCO Medicina Clinica), Azienda Ospedaliero-Universitaria di Trieste, Cattinara Teaching Hospital, Strada di Fiume, Trieste, Italy.
J Endocrinol Invest. 2016 Sep;39(9):1003-13. doi: 10.1007/s40618-016-0469-x. Epub 2016 Apr 20.
Benign thyroid nodules are an extremely common occurrence. Radiofrequency ablation (RFA) is gaining ground as an effective technique for their treatment, in case they become symptomatic. Here we review what are the current indications to RFA, its outcomes in terms of efficacy, tolerability, and cost, and also how it compares to the other conventional and experimental treatment modalities for benign thyroid nodules. Moreover, we will also address the issue of treating with this technique patients with cardiac pacemakers (PM) or implantable cardioverter-defibrillators (ICD), as it is a rather frequent occurrence that has never been addressed in detail in the literature.
良性甲状腺结节极为常见。射频消融(RFA)作为一种有效的治疗技术正在逐渐普及,适用于出现症状的结节。在此,我们回顾RFA目前的适应证、其在疗效、耐受性和成本方面的结果,以及它与其他用于治疗良性甲状腺结节的传统和实验性治疗方式相比如何。此外,我们还将探讨使用该技术治疗植入心脏起搏器(PM)或植入式心脏复律除颤器(ICD)的患者的问题,因为这是一种相当常见的情况,而文献中从未对此进行过详细讨论。